STUDY OF PHARMACISTS' AWARENESS IN THE IMPLEMENTATION OF PHARMACOGENEMIC CONSULTATION IN UKRAINE
DOI:
https://doi.org/10.11603/2312-0967.2026.1.15951Keywords:
personalized medicine, pharmacist, pharmacogenomics, counseling, educationAbstract
The aim of the work. To determine the current role of the pharmacist in the development of the pharmacogenomic consultation system in Ukraine, to assess the level of awareness, professional readiness and educational needs of pharmacists in the context of the implementation of personalized medicine.
Materials and methods. An analytical-sociological study was conducted among 460 pharmacists from five regions of Ukraine. The survey was conducted using a structured questionnaire with 25 questions covering socio-demographic parameters, awareness, motivation and barriers to professional development. Descriptive statistics, Pearson correlation analysis and expert evaluation were used. For a comprehensive assessment, the Genomic-Pharmacy Readiness Index (GPhR) was introduced.
Results. It was found that 27% of pharmacists are familiar with the basics of pharmacogenomics, 48% are partially familiar, 25% are not familiar with this area. The average GPhR score was 54±11 points, which indicates an average level of readiness to participate in genetic counseling. More than 70% of respondents expressed interest in specialized educational programs in personalized medicine. The main barriers identified were the lack of legal regulation of pharmacogenomic services (47%), lack of knowledge of genetics (68%) and lack of clinical skills (52%).
Conclusions. A pharmacist is one of the key participants in the personalized healthcare system. For the development of pharmacogenomic counseling in Ukraine, it is necessary to create an educational platform for continuous professional training, a regulatory framework and pilot models of interdisciplinary cooperation.
References
Relling MV, Evans WE. Pharmacogenomics in the clinic. Nature. 2022;604:52–60.
Phillips KA, Veenstra DL. Implementation of pharmacogenomics in clinical practice. Clin Pharmacol Ther. 2021;109(4):866-75.
Patrinos GP, van Schaik RHN. Pharmacogenomics education and implementation. Pharmacogenomics J. 2020;20(3):263-72. DOI: https://doi.org/10.1038/s41397-020-00199-0
Bouvy JC, De Winter BCM, Koch BCP. Pharmacogenomics and pharmacy practice in Europe. Eur J Hosp Pharm. 2023;30(1):15-21.
Abrahams E, Silver M. The Personalized Medicine Coalition report. Pharm Pract. 2022;20(4):117-26.
Kalaba M, Buzkova H, Slanar O. Pharmacists as coordinators of pharmacogenomic services. Res Social Adm Pharm. 2022;18(12):3857-66.
Jesenská L, Joppa M, Ondrejka I. Pharmacogenomic services in community pharmacy. Pharmacy (Basel). 2021;9(3):151.
Zastrozhin MS, Skryabin VY, Bryun EA. Barriers to pharmacogenomics implementation in Eastern Europe. Front Pharmacol. 2021;12:777168.
Lee KC, Ma JD. Pharmacogenomics in daily pharmacy practice. Am J Health Syst Pharm. 2021;78(18):1708-18.
Van Driest SL. The next decade of pharmacogenomics. Nat Med. 2024;30:202-110.
Yau EY, Shojania K, Banh HL. Integration of pharmacogenomics into pharmacy curricula. Am J Pharm Educ. 2020;84(9):ajpe7813.
World Health Organization. Ethics and governance of genomic data. Geneva: World Health Organization; 2022.
Gudzi A, Ivanenko O. Pharmacogenomics awareness among Ukrainian pharmacists. Ukr J Pharm Sci. 2023;(2):45-52.
European Medicines Agency. Guideline on the use of pharmacogenomics in drug development. Amsterdam: EMA; 2023.
Clinical Pharmacogenetics Implementation Consortium. Clinical Pharmacogenetics Implementation Consortium guidelines update. Clin Pharmacol Ther. 2023;114(1):12-9.
Swen JJ, Wilting I, De Boer A. Pharmacogenomics: from bench to bedside. Eur J Clin Pharmacol. 2024;80(2):123-34.
European Association for Clinical Pharmacology and Therapeutics. Clinical pharmacology and personalized medicine report. Eur J Clin Pharmacol. 2024;80(6):845-53.
Johnson JA, Cavallari LH. Pharmacogenetics in cardiovascular therapy. Circulation. 2024;149(3):215-28.
Organisation for Economic Co-operation and Development. Genomic innovation in health systems. Paris: OECD Publishing; 2025.
Ministry of Health of Ukraine. Digital health and personalized medicine strategy. Kyiv; 2025.
Kraidashenko OV, Kremzer OO, Samura T.O. Pharmacogenetic testing: current state of the issue. Current issues in pharmacy and medicine: science and practice [Internet]. 2024. DOI: https://doi.org/10.14739/2409-2932.2024.3.310994
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Pharmaceutical Review / Farmacevtičnij časopis
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The authors who publish their materials in this journal agree with the following terms:
- Authors reserve the right to authorship of their work and assign to the journal the right to first publish this work under the terms of the Creative Commons Attribution License, which allows other persons to freely distribute the published work with a mandatory reference to the authors of original work and the first publication of work in this journal
. - Authors have the right to make independent extra-exclusive work agreements in the form they are published by this journal (for example, posting work in an electronic repository of an institution or publishing as part of a monograph), provided that the link to the first publication of the work in this journal is maintained.
Journal policy allows and encourages publication of manuscripts on the Internet (for example, in institutions repositories or on personal websites), both before the publication of this manuscript and during its editorial review, as it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the citation of the published work (see The Effect of Open Access).
